Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era ανά Coates, L, O’Dwyer, J, Meads, D, Emery, P, Conaghan, PG, Helliwell, P

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial ανά O'Dwyer, J, Meads, D, Hulme, C, McParland, L, Brown, S, Coates, L, Moverley, A, Emery, P, Conaghan, P, Helliwell, P